The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
Year: 2001
Type: article
Source: PubMed
Authors: S Shan, A C Lockhart, W Y Saito, A M Knapp, K R Laderoute, M W Dewhirst
Institutions: Duke Medical Center, Duke University, SRI International
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2169034857
